Cargando…

Biological Role and Clinical Implications of MYOD1(L122R) Mutation in Rhabdomyosarcoma

SIMPLE SUMMARY: The myogenic differentiation 1 gene (MYOD1) p.L122R mutation was first discovered in a subset of clinically aggressive rhabdomyosarcomas in both adults and children. It occurs most frequently in spindle cell (Sp) or sclerosing (Sc) RMS, but also occasionally in ERMS, including 3% of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Carlo, Daniela, Chisholm, Julia, Kelsey, Anna, Alaggio, Rita, Bisogno, Gianni, Minard-Colin, Veronique, Jenney, Meriel, Dávila Fajardo, Raquel, Merks, Johannes H. M., Shipley, Janet M., Selfe, Joanna L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046495/ https://www.ncbi.nlm.nih.gov/pubmed/36980529 http://dx.doi.org/10.3390/cancers15061644

Ejemplares similares

Maintenance Chemotherapy for Patients with Rhabdomyosarcoma
por: Bisogno, Gianni, et al.
Publicado: (2023)

Shedding a Light on the Challenges of Adolescents and Young Adults with Rhabdomyosarcoma
por: Ferrari, Andrea, et al.
Publicado: (2022)

Metastatic Rhabdomyosarcoma: Results of the European Paediatric Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study
por: Schoot, Reineke A., et al.
Publicado: (2022)

Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2023)

MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes
por: Rekhi, Bharat, et al.
Publicado: (2016)

Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG‐RMS2005 study
por: Terwisscha van Scheltinga, Sheila E. J., et al.
Publicado: (2020)

DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma
por: Virgone, Calogero, et al.
Publicado: (2015)

Patient Reported Outcomes and Measures in Children with Rhabdomyosarcoma
por: van Gorp, Marloes, et al.
Publicado: (2023)

Disruption of the MyoD/p21 Pathway in Rhabdomyosarcoma
por: Weintraub, Michael, et al.
Publicado: (1997)

Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation
por: Choo, Florence, et al.
Publicado: (2022)

Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience
por: Vaarwerk, Bas, et al.
Publicado: (2019)

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium
por: Shern, Jack F., et al.
Publicado: (2021)

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma
por: Bonvini, P, et al.
Publicado: (2013)

MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas
por: Missiaglia, Edoardo, et al.
Publicado: (2017)

An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review
por: Norman, Gill, et al.
Publicado: (2015)

The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
por: O’Brien, Eleanor M., et al.
Publicado: (2018)

The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma
por: Mohamed, Abdalla, et al.
Publicado: (2016)

Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2021)

Prostatic Stromal Sarcoma in an Adolescent: The Role of Chemotherapy
por: Cavaliere, Elena, et al.
Publicado: (2014)

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells
por: O’Brien, Eleanor, et al.
Publicado: (2023)

Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding
por: Li, Stephen, et al.
Publicado: (2019)

Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma
por: Gasparini, Patrizia, et al.
Publicado: (2016)

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A
por: Walters, Zoë S., et al.
Publicado: (2021)

Developments in the Surgical Approach to Staging and Resection of Rhabdomyosarcoma
por: Terwisscha van Scheltinga, Sheila, et al.
Publicado: (2023)

Hyper-Activation of Notch3 Amplifies the Proliferative Potential of Rhabdomyosarcoma Cells
por: De Salvo, Maria, et al.
Publicado: (2014)

CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG
por: Liu, Zhihui, et al.
Publicado: (2020)

SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function
por: Skrzypek, Klaudia, et al.
Publicado: (2018)

Actin-related protein 5 functions as a novel modulator of MyoD and MyoG in skeletal muscle and in rhabdomyosarcoma
por: Morita, Tsuyoshi, et al.
Publicado: (2022)

Imaging in rhabdomyosarcoma: a patient journey
por: de Vries, Isabelle S. A., et al.
Publicado: (2023)

Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee
por: van Ewijk, Roelof, et al.
Publicado: (2023)

Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2020)

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
por: Gatz, Susanne A., et al.
Publicado: (2019)

FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas
por: Milton, Christopher I., et al.
Publicado: (2021)

Correction to: Imaging in rhabdomyosarcoma: a patient journey
por: de Vries, Isabelle S. A., et al.
Publicado: (2023)

Treatment of Rhabdomyosarcoma in Children and Adolescent from Four Low Health Expenditures Average Rates Countries
por: Mazic, Maja Cesen, et al.
Publicado: (2020)

Prognostic Value of Circulating IGFBP2 and Related Autoantibodies in Children with Metastatic Rhabdomyosarcomas
por: Poli, Elena, et al.
Publicado: (2020)

Clinical significance of circulating tumor cells and cell‐free DNA in pediatric rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2022)

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study
por: Ruhen, Olivia, et al.
Publicado: (2022)

Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance
por: Poli, Elena, et al.
Publicado: (2021)

Targeting the Insulin-Like Growth Factor Pathway in Rhabdomyosarcomas: Rationale and Future Perspectives
por: Martins, Ana Sofia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7k2liohqbl113or2do093a6ljh